ReBio Technologies is a global brand that specializes in the development of innovative medical products. With a highly experienced and talented team, the company focuses on translational development and regulatory strategy/execution. The executive management, including CEO Vinod Vijayakumar, brings over 20 years of expertise in early-stage medical product development.

ReBio Technologies is known for its expertise in biomaterials and polymer-based sustained release formulation development. Their extensive range of products includes Cervidil®/Propess and innovative controlled drug delivery platforms. The brand is driven by a commitment to improving healthcare outcomes and strives to bring cutting-edge solutions to the market.

Supported by a distinguished board of directors and world-class advisors, ReBio Technologies is at the forefront of the industry. Collaborations with leading experts in the field of ophthalmology, such as Professor Arto Urtti and Professor Peter Adamson, ensure that the brand remains focused on enhancing eye health. With offices in Hong Kong, Finland, and the United Kingdom, ReBio Technologies operates on a global scale.

Their dedication to smart chemistry and scientific excellence has positioned them as a key player in the medical technology industry. Contact them today to learn more about their innovative solutions